ArticleJournal of atrial fibrillation2019
Outcomes of Hemorrhagic Stroke Patients with Atrial Fibrillation or Flutter.
Article in Journal of atrial fibrillation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hemorrhagic stroke and atherogenic markers - is there any relation?Journal of family medicine and primary care · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHemorrhagic stroke is a life-threatening complication, and may be particularly prevalent in patients with atrial fibrillation/flutter (AF/AFL) due to their need for anticoagulation. We sought to estimate in-hospital mortality, length of stay (LOS) and in-patient treatment cost of patients with AF/AFL admitted with hemorrhagic stroke.
methodsWe used the 2008-2011 National Inpatient Sample to identify adult AF/AFL patients with a principle discharge diagnosis of subarachnoid or intracerebral hemorrhage. Endpoints of interest included in-hospital mortality, LOS, and hospital treatment costs (2015 US$).
resultsIn-hospital mortality for subarachnoid and intracerebral hemorrhage was 31.3% and 31.8%, respectively. Patients had a median LOS of 5 days and 25% of patients accrued costs in excess of $24,107/stay.
conclusionsAdmissions for hemorrhagic stroke among patients with AF/AFL were associated with substantial in-hospital mortality and treatment costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.